1. Home
  2. WSC vs CRSP Comparison

WSC vs CRSP Comparison

Compare WSC & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WillScot Mobile Mini Holdings Corp.

WSC

WillScot Mobile Mini Holdings Corp.

HOLD

Current Price

$21.36

Market Cap

4.8B

Sector

Industrials

ML Signal

HOLD

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$59.23

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSC
CRSP
Founded
1944
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Misc Corporate Leasing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.8B
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
WSC
CRSP
Price
$21.36
$59.23
Analyst Decision
Buy
Buy
Analyst Count
8
17
Target Price
$24.14
$70.29
AVG Volume (30 Days)
3.1M
1.5M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
1.27%
N/A
EPS Growth
N/A
N/A
EPS
0.41
N/A
Revenue
$2,281,446,000.00
$289,590,000.00
Revenue This Year
N/A
$807.72
Revenue Next Year
$3.31
$172.52
P/E Ratio
$51.88
N/A
Revenue Growth
N/A
9169.85
52 Week Low
$14.91
$44.12
52 Week High
$29.77
$78.48

Technical Indicators

Market Signals
Indicator
WSC
CRSP
Relative Strength Index (RSI) 36.00 62.10
Support Level $21.40 $50.45
Resistance Level $22.87 $60.10
Average True Range (ATR) 1.12 2.42
MACD -0.14 0.74
Stochastic Oscillator 6.62 73.45

Price Performance

Historical Comparison
WSC
CRSP

About WSC WillScot Mobile Mini Holdings Corp.

WillScot Holdings Corp designs, delivers, and services on-site, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company include modular office complexes, mobile offices, classrooms, blast-resistant modules, clearspan structures, sanitation solutions, portable storage containers, and climate-controlled containers and trailers.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: